Accesibility Adjustments

Choose the right accessibility profile for you
OFF ON
Highlight Links Highlights all the links on the site!
OFF ON
Pause Animations Animations will be paused on the site!
OFF ON
Dyslexia Font Dyslexia Font will be applied on the site!
OFF ON
Hide Images All images will be hidden on the site!
Choose the right accessibility profile for you
Adjust Font Sizing
Default
High Saturation
High Contrast
Light Contrast
Dark Contrast
Adjust Letter Spacing
Default
Adjust Line Height
Default
Speak Mode
Align Center
Align Left
Align Right
Godina Rad Podtip Autor/Koautor Indeks Vrijednost
2024 1. Gandhi S, Patankar D, Kashiramka S, Rathore AS. The economics of translating a biosimilar from lab to market in India. Ann N Y Acad Sci. 2024 Nov;1541(1):219-229, Epub 2024 Nov 13. PMID: 39538969 R1 autor B-9 6
2024 2. Jakubowski S, Kawalec P, Holko P, Kowalska-Bobko I, Kamusheva M, Petrova G, Draganić P, Fuksa L, Männik A, Ispán F, Briedis V, Bianchi I, Paveliu MS and Tesar T (2024) Clinical aspects of reimbursement policies for orphan drugs in Central and Eastern European countries. Front. Pharmacol. 15:1369178 R1 autor B-9 6
2024 3. Larsen RE, Hole K, Selle ML, Johannessen Landmark C, Krogstad T and Holm LB (2024) Access to a tailored mobile application enhances medication adherence among young users of antidepressants. Front. Pharmacol. 15:1379700 R1 autor B-9 6
2024 4. Bischof T, Nagele F, Kalkofen MM, Blechschmidt MEO, Domanovits H, Zeitlinger M, Schoergenhofer C and Cacioppo F (2024) Drug-drug-interactions in patients with atrial fibrillation admitted to the emergency department. Front. Pharmacol. 15:1432713 R1 autor B-9 6
2024 Ideks citiranosti B-17
Stanford lista: Ne
Broj citata na Google Scholaru: 0
H-indeks: 0

INPA=24